Glooko's app connecting blood glucose monitors with the iPhone is now available for Wal-Mart's glucometers.
Johnson & Johnson, already the world's largest health products maker, could have its eye on Edwards Lifesciences and St. Jude Medical as potential acquisitions, analysts say.
A hacker and McAfee researcher demonstrates how an insulin pump can be controlled wirelessly and forced to inject a lethal dose from a distance.
MASSDEVICE ON CALL — A modern insulin pump can be hacked from 300 feet away and told to deliver a lethal dose of insulin, a hacker and researcher for computer security giant McAfee proved.
Using a laptop and a custom-made antennae, Barnaby Jack's software broke through the insulin pump's security and altered its program to dump its contents, injected a potentially lethal dose of the hormone into a dummy pancreas used for demonstration purposes.
Medtronic lands FDA approval for its mySentry remote glucose monitor.
MASSDEVICE ON CALL — Medtronic (NYSE:MDT) landed FDA approval for its mySentry remote glucose monitor, which delivers real-time insulin pump stats and glucose trends.
The Minneapolis, Minn.-based medical device titan's system links with the MiniMed Paradigm insulin pump to allow caregivers to set alarms and remotely monitor patients' glucose levels.
Bin Laden's kidney disease, St. Jude's CEO slams Medtronic, med-tech to save Steve Jobs, DNA tests show incest and Bill Hawkins on leaving MDT were the most popular medical device stories of 2011.
Welcome to MassDevice's annual audit of the ups, downs and in-betweens of the year that was. For the medical device industry, 2011 was more or less defined by a nagging sense of uncertainty that hung over the world's med-tech companies like a grey cloud above a summer picnic.
But what did we learn from all the conjecture? In truth, not much. The year ends much as it began, full of questions with no cut and dry answers as we turn the calenFdar over into the new year.
French authorities may ask 30,000 women to have a potentially defective type of breast implant removed.
MASSDEVICE ON CALL — French authorities need to decide whether or not they're going to ask 30,000 women to have their breast implants removed.
The potentially defective implants were supplied by Poly Implant Prothese and contain a non-authorized silicone gel that causes high rupture rates.
"We have to remove all these implants," Dr. Laurent Lantieri, a plastic surgeon on a special committee investigating the issue told the Liberation newspaper. "We're facing a health crisis, linked to a fraud."